Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing

被引:1
|
作者
Song, Ju Sun [1 ,2 ]
机构
[1] GC Labs, GC Genome, Yongin, South Korea
[2] GC Labs, 107 Ihyeon Ro 30beon Gil, Yongin 16924, South Korea
关键词
HEALTH-ORGANIZATION CLASSIFICATION; SOMATIC MUTATIONS; 5TH EDITION; LYMPHOMA; RESISTANCE;
D O I
10.5045/br.2023.2023196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:224 / 228
页数:5
相关论文
共 50 条
  • [21] Clinical utility of custom-designed NGS panel testing in pediatric tumors
    Surrey, Lea F.
    MacFarland, Suzanne P.
    Chang, Fengqi
    Cao, Kajia
    Rathi, Komal S.
    Akgumus, Gozde T.
    Gallo, Daniel
    Lin, Fumin
    Gleason, Adam
    Raman, Pichai
    Aplenc, Richard
    Bagatell, Rochelle
    Minturn, Jane
    Mosse, Yael
    Santi, Mariarita
    Tasian, Sarah K.
    Waanders, Angela J.
    Sarmady, Mahdi
    Maris, John M.
    Hunger, Stephen P.
    Li, Marilyn M.
    GENOME MEDICINE, 2019, 11 (1)
  • [22] Clinical utility of custom-designed NGS panel testing in pediatric tumors
    Lea F. Surrey
    Suzanne P. MacFarland
    Fengqi Chang
    Kajia Cao
    Komal S. Rathi
    Gozde T. Akgumus
    Daniel Gallo
    Fumin Lin
    Adam Gleason
    Pichai Raman
    Richard Aplenc
    Rochelle Bagatell
    Jane Minturn
    Yael Mosse
    Mariarita Santi
    Sarah K. Tasian
    Angela J. Waanders
    Mahdi Sarmady
    John M. Maris
    Stephen P. Hunger
    Marilyn M. Li
    Genome Medicine, 11
  • [23] Clinical Utility of Next Generation Sequencing (NGS) Panel for Recurrent/Advanced Stage Gynecological Malignancies
    Lim, Diana
    Lee, Xiao-Wen
    Koh, Xue-Qing
    Pang, Brendan
    Soong, Richie
    Tan, David S. P.
    LABORATORY INVESTIGATION, 2017, 97 : 297A - 298A
  • [24] Clinical Utility of Next Generation Sequencing (NGS) Panel for Recurrent/Advanced Stage Gynecological Malignancies
    Lim, Diana
    Lee, Xiao-Wen
    Koh, Xue-Qing
    Pang, Brendan
    Soong, Richie
    Tan, David S. P.
    MODERN PATHOLOGY, 2017, 30 : 297A - 298A
  • [25] Ultra deep panel-based NGS of cancer-relevant genes as treatment decision support
    Doecker, D.
    Menzel, M.
    Armeanu-Ebinger, S.
    Rinckleb, A.
    Biskup, S.
    BREAST, 2015, 24 : S48 - S48
  • [26] Unusual Results Identified by a Targeted Clinical Next-Generation Sequencing (NGS) Hematologic Malignancy Panel
    Frederick, L.
    Hubbard, M.
    Bessonen, K.
    Viswanatha, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 964 - 965
  • [27] Comparison of a comprehensive NGS profiling assay and conventional molecular testing approaches for detection of clinically relevant alterations in NSCLC
    Weingartner, Elizabeth
    Gerding, Kelly M. R.
    Cerquiera, Gustavo
    Gault, Christopher
    Hernandez, James
    Valkenburg, Kenneth
    Keefer, Laurel
    Sagini, Eileen
    Johng, Dorhyun
    Gilley, Caitlin
    Ganey, Colby
    Ettehadieh, Leila
    Denier, Diandra
    Oliveras, Christina
    Joshi, Kartikeya
    Kong, Eric
    Papp, Eniko
    Greer, Amy
    White, James R.
    Nichol, Donna
    Simmons, John
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [28] Analysis and Characterization of Hematologic Cancers Using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
    Carson, A. R.
    Patay, B. A.
    Graham, S. M.
    McClain, V.
    Xie, Z.
    Stenzel, T.
    Miller, J. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S9 - S10
  • [29] ANALYSIS AND CHARACTERIZATION OF HEMATOLOGIC CANCERS USING A COMPREHENSIVE NGS PANEL COMPRISED OF DNA AND RNA BAITS TARGETING 704 GENES
    Carson, A. R.
    Patay, B. A.
    McClain, V.
    Xie, Z.
    Stenzel, T.
    Miller, J. E.
    HAEMATOLOGICA, 2017, 102 : 5 - 5
  • [30] Next-generation sequencing panel for dermatology genes: making the sequencing revolution clinically relevant
    Drury, S.
    Waelchli, R.
    Glover, M.
    Harper, J. I.
    Lomas, D.
    O'Shaughnessy, R.
    Lench, N.
    Kinsler, V. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (01) : E8 - E8